Register entryShortage reported
Nephron Pharmaceuticals Corporation
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 12
- Live patents
- 0
- Shortage listings
- 2
- Countries
- 0
Alert
Drug shortage listings
2| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Sterile Water InjectionOther | Sterile Water, Injection, 1 mL/1 mL (NDC 0487-6105-01) | Current | Limited Availability | 23 Nov 20214 Aug 2026 |
| Albuterol Sulfate SolutionPulmonary/Allergy, Pediatric | Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 0487-9901-30) | Resolved | - | 25 Oct 202227 Aug 2026 |
Catalogue
Drug listings by form and route
1212 active NDC listings: 11 human prescription drug, 1 human otc drug. By marketing category: ANDA 11, OTC MONOGRAPH DRUG 1.
| Dosage form | NDCs |
|---|---|
| solution | 7 |
| injection | 3 |
| inhalant | 2 |
| Route | NDCs |
|---|---|
| respiratory (inhalation) | 9 |
| intramuscular | 2 |
| intravenous | 2 |
| subcutaneous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| nephron pharmaceuticals corporation | 12 |
Catalogue
Marketed products
12| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Albuterol Sulfate | Albuterol Sulfate | solution, respiratory (inhalation) | 0487-0301ANDA |
| Albuterol Sulfate | Albuterol Sulfate | solution, respiratory (inhalation) | 0487-9501ANDA |
| Albuterol Sulfate | Albuterol Sulfate | solution, respiratory (inhalation) | 0487-9901ANDA |
| Albuterol Sulfate | Albuterol Sulfate | solution, respiratory (inhalation) | 0487-9904ANDA |
| Budesonide | BUDESONIDE | inhalant, respiratory (inhalation) | 0487-9601ANDA |
| Budesonide | BUDESONIDE | inhalant, respiratory (inhalation) | 0487-9701ANDA |
| Ipratropium Bromide | Ipratropium Bromide | solution, respiratory (inhalation) | 0487-9801ANDA |
| Ipratropium Bromide and Albuterol Sulfate | Ipratropium Bromide and Albuterol Sulfate | solution, respiratory (inhalation) | 0487-0201ANDA |
| Ketorolac Tromethamine | Ketorolac Tromethamine | injection, intramuscular | 0487-6232ANDA |
| S2 | racepinephrine hydrochloride | solution, respiratory (inhalation) | 0487-5901OTC MONOGRAPH DRUG |
| Sodium Chloride | Sodium Chloride | injection, intravenous | 0487-4301ANDA |
| Sterile Water | Sterile Water | injection, intramuscular, intravenous, subcutaneous | 0487-6105ANDA |
Compare
Other companies listing albuterol sulfate
- Cardinal Health 418, Inc.34 sites · 833 NDC
- CIPLA PHARMACEUTICALS LIMITED7 sites · 368 NDC
- Teva Pharmaceutical Industries Ltd.6 sites · 668 NDC
- Spectrum Pharmaceuticals, Inc.6 sites · 240 NDC
- Pharma Packaging Solutions, LLC dba Tjoapack, LLC5 sites · 667 NDC
- Sandoz Industrial Products S.A5 sites · 441 NDC
- Hikma Pharmaceuticals USA Inc.4 sites · 763 NDC
- International Medication Systems, Ltd.3 sites · 2,801 NDC
- Supriya Lifescience Limited3 sites · 30 NDC
- Lusochimica SPA2 sites · 13 NDC
Enquiry
Common questions
- Is Nephron Pharmaceuticals Corporation FDA approved?
- Nephron Pharmaceuticals Corporation holds no registered establishment of its own; 12 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Nephron Pharmaceuticals Corporation make?
- 12 products are listed under Nephron Pharmaceuticals Corporation in the openFDA NDC Directory, most often as solution; injection; inhalant. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
- Are any Nephron Pharmaceuticals Corporation products in shortage?
- 1 presentation is currently listed in the FDA drug shortage database under Nephron Pharmaceuticals Corporation, covering Sterile Water Injection.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.